GN Store Nord A/S (CPH:GN)
Denmark · Delayed Price · Currency is DKK 97.30
+0.84 (0.87%)
Aug 8, 2025, 4:59 PM CET
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 14.17 billion as of August 8, 2025. Its market cap has decreased by -43.96% in one year.
Market Cap
14.17B
Enterprise Value
25.15B
Revenue
17.67B
Ranking
n/a
PE Ratio
17.60
Stock Price
97.30
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 14.17B, an increase of 4,192.22%. That is a compound annual growth rate of 12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 14.17B | -27.24% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | 62.76B | 55.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,286.37B |
| Coloplast | 132.80B |
| Genmab | 84.69B |
| Demant | 53.17B |
| ALK-Abelló | 40.21B |
| H. Lundbeck | 32.91B |
| Ambu A/S | 23.88B |
| Zealand Pharma | 22.06B |